Jin Gu

638 total citations
17 papers, 430 citations indexed

About

Jin Gu is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Jin Gu has authored 17 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Jin Gu's work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Jin Gu is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (7 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Jin Gu collaborates with scholars based in China, United States and Taiwan. Jin Gu's co-authors include Lan Yao, Shenjie Tang, Xiaohui Hao, Yidian Liu, Zhanjun Zhang, Gang Liu, Meiying Wu, Xia Zhang, Heping Xiao and Wenwen Sun and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Frontiers in Immunology.

In The Last Decade

Jin Gu

17 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin Gu China 11 295 213 109 67 59 17 430
Hongqiu Pan China 16 264 0.9× 208 1.0× 76 0.7× 92 1.4× 75 1.3× 46 515
Ming-Gui Wang China 13 203 0.7× 170 0.8× 83 0.8× 76 1.1× 63 1.1× 34 393
Marcus M. Mücke Germany 15 117 0.4× 453 2.1× 92 0.8× 76 1.1× 63 1.1× 39 710
Sergo Vashakidze Georgia 11 351 1.2× 252 1.2× 167 1.5× 83 1.2× 25 0.4× 20 517
Shouquan Wu China 14 205 0.7× 173 0.8× 53 0.5× 94 1.4× 85 1.4× 37 413
Trana Hussaini Canada 12 155 0.5× 296 1.4× 68 0.6× 44 0.7× 38 0.6× 47 518
Jennifer Roe United Kingdom 12 375 1.3× 290 1.4× 110 1.0× 113 1.7× 68 1.2× 16 636
Peter Langmann Germany 15 348 1.2× 151 0.7× 47 0.4× 60 0.9× 19 0.3× 37 555
Radhika Venugopal India 5 278 0.9× 121 0.6× 76 0.7× 49 0.7× 41 0.7× 8 477
Rehab Badawi Egypt 13 82 0.3× 230 1.1× 74 0.7× 55 0.8× 17 0.3× 45 442

Countries citing papers authored by Jin Gu

Since Specialization
Citations

This map shows the geographic impact of Jin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Gu more than expected).

Fields of papers citing papers by Jin Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Gu. The network helps show where Jin Gu may publish in the future.

Co-authorship network of co-authors of Jin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Gu. A scholar is included among the top collaborators of Jin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Gu. Jin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhū, Lìyǐng, Bo Wang, Jin Gu, et al.. (2024). IFNγ-secreting T cells that highly express IL-2 potently inhibit the growth of intracellular M. tuberculosis in macrophages. Frontiers in Immunology. 15. 1469118–1469118. 1 indexed citations
2.
Du, Yiqi, Jin Gu, Yang Yu, et al.. (2024). Efficacy and safety of bicyclol for treating patients with antituberculosis drug-induced liver injury. The International Journal of Tuberculosis and Lung Disease. 28(1). 6–12. 1 indexed citations
3.
4.
Ma, Xiaoxiao, S. Yu, Jin Gu, Hong Jiang, & Y. Shan. (2023). AB0564 TIGIT ACTIVATOR ALLEVIATES SYSTEMIC LUPUS ERYTHEMATOSUS BY NEGATIVELY REGULATING TH1-LIKE TREG CELL DIFFERENTIATION. Annals of the Rheumatic Diseases. 82. 1479–1479. 1 indexed citations
5.
Wang, Lan, Lan Zhao, Feng Li, et al.. (2022). Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients. The Clinical Respiratory Journal. 16(3). 182–189. 19 indexed citations
6.
7.
Sun, Wenwen, Hong Li, & Jin Gu. (2020). Up‐regulation of microRNA‐574 attenuates lipopolysaccharide‐ or cecal ligation and puncture‐induced sepsis associated with acute lung injury. Cell Biochemistry and Function. 38(7). 847–858. 17 indexed citations
8.
9.
10.
Shen, Hongbo, Jin Gu, Heping Xiao, et al.. (2016). Selective Destruction of Interleukin 23–Induced Expansion of a Major Antigen–Specific γδ T-Cell Subset in Patients With Tuberculosis. The Journal of Infectious Diseases. 215(3). jiw511–jiw511. 27 indexed citations
11.
Yang, Enzhuo, Jin Gu, Feifei Wang, et al.. (2016). Recombinant BCG prime and PPE protein boost provides potent protection against acute Mycobacterium tuberculosis infection in mice. Microbial Pathogenesis. 93. 1–7. 15 indexed citations
12.
Sun, Qin, Qing Zhang, Jin Gu, et al.. (2016). Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study. Pharmacoepidemiology and Drug Safety. 25(8). 908–917. 30 indexed citations
13.
Gu, Jin, Shenjie Tang, Shouyong Tan, et al.. (2015). An open-label, randomized and multi-center clinical trial to evaluate the efficacy of Silibinin in preventing drug-induced liver injury.. PubMed. 8(3). 4320–7. 37 indexed citations
14.
Tang, Shenjie, Lan Yao, Xiaohui Hao, et al.. (2015). Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis: Prospective, Multicenter, Randomized Controlled Study in China. Clinical Infectious Diseases. 60(9). 1361–1367. 104 indexed citations
15.
Tang, Shenjie, Lan Yao, Xiaohui Hao, et al.. (2014). Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. European Respiratory Journal. 45(1). 161–170. 119 indexed citations
16.
Tang, Shenjie, Heping Xiao, Jin Gu, et al.. (2011). Efficacy And Safety Of Linezolid For The Treatment Of Extensively Drug Resistant Tuberculosis. A1834–A1834. 2 indexed citations
17.
Tang, Shenjie, Qing Zhang, Jin Gu, et al.. (2011). Efficacy and Safety of Linezolid in the Treatment of Extensively Drug-Resistant Tuberculosis. Japanese Journal of Infectious Diseases. 64(6). 509–512. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongqiu Pan Breakdown of academic impact, for papers by Ming-Gui Wang Breakdown of academic impact, for papers by Marcus M. Mücke Breakdown of academic impact, for papers by Sergo Vashakidze Breakdown of academic impact, for papers by Shouquan Wu Breakdown of academic impact, for papers by Trana Hussaini Breakdown of academic impact, for papers by Jennifer Roe Breakdown of academic impact, for papers by Peter Langmann Breakdown of academic impact, for papers by Radhika Venugopal Breakdown of academic impact, for papers by Rehab Badawi
Rankless by CCL
2026